Early Administration of Rifampicin Does Not Induce Increased Resistance in Septic Two-Stage Revision Knee and Hip

Leonard Grünwald1,2, Benedikt Paul Blersch1,2, Bernd Fink1,3

  • 1Department of Joint Replacement, General and Rheumatic Orthopaedics, Orthopaedic Clinic Markgröningen gGmbH, Kurt-Lindemann-Weg 10, 71706 Markgröningen, Germany.

Insights

Starting rifampicin on the second postoperative day for periprosthetic joint infection (PJI) treatment showed low rates of rifampicin resistance (0.9%-1.4%). This timing is safe and effective for two-stage revision surgery in PJI patients.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Pharmacology

Background:

  • Periprosthetic joint infection (PJI) is a serious complication following arthroplasty, affecting approximately 2% of patients.
  • Optimized antibiotic regimens are crucial for PJI management, with rifampicin often used in combination therapy.
  • The optimal timing for initiating rifampicin treatment to prevent resistance remains debated.

Purpose of the Study:

  • To evaluate the safety and efficacy of initiating rifampicin combination therapy on the second postoperative day in patients undergoing two-stage revision surgery for PJI.
  • To assess the incidence of rifampicin resistance development during and after treatment.

Main Methods:

  • Retrospective study of 212 patients with PJI undergoing two-stage revision surgery (THA and TKA).
  • Patients received individualized rifampicin combination therapy starting on the second postoperative day after debridement and foreign material removal.
  • Rifampicin resistance was monitored at spacer explantation and long-term follow-up.

Main Results:

  • A low incidence of rifampicin resistance was observed: 0.9% at spacer explantation and 1.4% at long-term follow-up.
  • The overall reinfection rate requiring further treatment was 11.8% in the study group.
  • No significant increase in resistance was noted between the first and second stages of surgery.

Conclusions:

  • Initiating rifampicin combination therapy on the second postoperative day is associated with a low risk of developing rifampicin resistance in PJI patients.
  • This therapeutic approach appears safe and effective for two-stage revision surgery, allowing sufficient concentrations of companion antibiotics.
  • Early administration of rifampicin on postoperative day two is a viable strategy in managing periprosthetic joint infections.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
48
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
130
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
249
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
36
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
23